Senior Director - ExploR&D Business Operations and Alliance Management at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor's degree
10+ years of extensive experience in contract negotiations (either business development or vendor relationships) across drug discovery and development
Strong understanding of pharmaceutical R&D operations, drug development lifecycle, regulatory environment, and biotech business models
Scientific background required for technical credibility when engaging with R&D partners
Experience managing a team focused on R&D contract negotiations
Experience managing relationships with biotech companies
Proficient in conflict resolution, negotiation, and stakeholder management

Responsibilities

Lead alliance management across the entire ExploR&D portfolio, serving as the primary interface between Lilly and biotech partners to maintain strategic alignment and foster strong relationships
Establish and oversee performance monitoring frameworks and tools for KPI tracking to ensure both parties meet contractual obligations and achieve collaboration objectives
Serve as the primary escalation point for partners, proactively identifying and resolving complex partnership challenges while maintaining partner satisfaction and protecting Lilly's strategic interests
Coordinate and oversee amendments and contract modifications to existing ExploR&D collaboration agreements, ensuring alignment with business objectives, compliance requirements, and partner expectations throughout the lifecycle
Lead a team of contract negotiators responsible for agreements across drug discovery and development, facilitating consistent contract strategy, risk assessment, and risk mitigation
Oversee cross-functional coordination with the business, legal, finance, and other teams to align internal stakeholders and ensure integrated support for collaborations
Drive continuous improvement in processes, tools, and frameworks to improve contracts and alliance management and enhance operational efficiency, partner satisfaction, and collaboration outcomes

Skills

Alliance Management

Business Operations

Contract Negotiation

Strategic Oversight

Partner Relationship Management

Biotech Collaboration

Drug Discovery

Program Execution

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free